Search Tristar Technology Group L.L.C Products
Founded in 2003, TriStar has pioneered the commercialization of very high-density tissue arrays (TMAs) for the large-scale prognosis analysis of gene/protein expression in human normal and cancer tissues. In addition to over 2.5 million archived samples (100,000 as TMAs), we offer a range of services including histology labs, analytical platforms, access to top academic opinion leaders etc.
Still Need More Help?
If you have sales questions relative to particular products or to your line of research,
please contact the CEDARLANE® sales department and have all of your questions answered
in a timely and professional manner.